MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70171 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Wei-Ying Jen und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Bone Marrow, Blast Crisis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
MECOM rearrangements ( MECOM ‐r) are acute myeloid leukaemia (AML)‐defining, regardless of blast percentage or MECOM fusion partner. We sought to investigate if blast percentage or MECOM ‐r partner was associated with overall survival (OS). We included 152 adult patients with newly diagnosed MECOM ‐r and classified blast percentage into
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Wei-Ying Jen, Jennifer Croden, Koji Sasaki, Alex Bataller, Guillermo Montalban-Bravo, Gautam Borthakur, Sanam Loghavi, Nicholas J Short, Uday Popat, Naveen Pemmaraju, Guillermo Garcia-Manero, Farhad Ravandi, Naval G Daver, Courtney D DiNardo, Hagop M Kantarjian, Tapan M Kadia
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jen, W. Y., Tang, G., Kugler, E., Croden, J., Sasaki, K., Bazinet, A., Bataller, A., Montalban-Bravo, G., Borthakur, G., Toruner, G. A., Loghavi, S., Short, N. J., Issa, G. C., Bouligny, I. M., Pierce, S., Popat, U., Pemmaraju, N., Jabbour, E., Garcia-Manero, G., …, & Kadia, T. M. (2025). MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.70171
Vancouver
Jen WY, Tang G, Kugler E, Croden J, Sasaki K, Bazinet A, et al. MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia. British Journal of Haematology. 2025. doi:10.1111/bjh.70171
BibTeX
@article{Jen2025,
author = {Jen, Wei-Ying and Tang, Guilin and Kugler, Eitan and Croden, Jennifer and Sasaki, Koji and Bazinet, Alexandre and Bataller, Alex and Montalban-Bravo, Guillermo and Borthakur, Gautam and Toruner, Gokce A and Loghavi, Sanam and Short, Nicholas J and Issa, Ghayas C and Bouligny, Ian M and Pierce, Sherry and Popat, Uday and Pemmaraju, Naveen and Jabbour, Elias and Garcia-Manero, Guillermo and Bhalla, Kapil and Ravandi, Farhad and Daver, Naval G and DiNardo, Courtney D and Kantarjian, Hagop M and Kadia, Tapan M},
title = {MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70171}
}
EUVIMED